Effect of omega-3 fatty acids on haemostatic functions in urocortin-treated obese rats

Journal of Physiology and Biochemistry

Volumn 70, Issue 3, 2014, Pages 809-820

  El Gendy, Ahmed A ^a   Abbas, Amr M ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Coagulation; High fat diet; Insulin resistance; Lipid profile; Omega 3 fatty acids; Platelet aggregation; Urocortin

Indexed keywords

GLUCOSE BLOOD LEVEL; LIPID; OMEGA 3 FATTY ACID; UROCORTIN;

ADVERSE EFFECTS; ANIMAL; BLOOD; BLOOD CLOTTING; DIET THERAPY; DISEASE MODEL; DRUG EFFECTS; EATING; GLUCOSE BLOOD LEVEL; HEMOSTASIS; INSULIN RESISTANCE; LIPID DIET; MALE; METABOLISM; OBESITY; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT; THROMBOCYTE AGGREGATION;

ANIMALS; BLOOD COAGULATION; BLOOD GLUCOSE; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; EATING; FATTY ACIDS, OMEGA-3; HEMOSTASIS; INSULIN RESISTANCE; LIPIDS; MALE; OBESITY; PLATELET AGGREGATION; RATS; RATS, SPRAGUE-DAWLEY; UROCORTINS;

EID: 84933037289     PISSN: 11387548     EISSN: 18778755     Source Type: Journal    
DOI: 10.1007/s13105-014-0350-3     Document Type: Article

References (69)

1. Afifi MM, Abbas AM (2011) Monosodium glutamate versus diet induced obesity in pregnant rats and their offspring. Acta Physiol Hung 98(2):177–188
2. Anfossi G, Russo I, Trovati M (2006) Platelet resistance to the anti-aggregating agents in the insulin resistant states. Curr Diabetes Rev 2:409–430
3. Asakawa A, Inui A, Ueno N, Makino S, Fujino MA, Kasuga M (1999) Urocortin reduces food intake and gastric emptying in lean and ob/ob obese mice. Gastroenterology 116:1287–1292
4. Badimon L, Hernández Vera R, Vilahur G (2013) Atherothrombotic risk in obesity. Hamostaseologie 33:259–268
5. Basili S, Pacini G, Guagnano MT et al (2006) Insulin resistance as a determinant of platelet activation in obese women. J Am Coll Cardiol 48:2531–2538
6. Bessesen DH (2008) Update on obesity. J Clin Endocrinol Metab 93(6):2027–2034
7. Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetnam PM, Elwood PC, Deadman NM (1989) Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction. Lancet 2:757–761
8. Cacho J, Sevillano J, de Castro J, Herrera E, Ramos MP (2008) Validation of simple indexes to assess insulin sensitivity during pregnancy in wistar and Sprague–Dawley rats. Am J Physiol Endocrinol Metab 295:E1269–E1276
9. Cade JE, Burley VJ, Greenwood DC, UK Women’s Cohort Study Steering Group (2004) The UK Women’s Cohort Study: Comparison of vegetarians, fish-eaters and meat-eaters. Public Health Nutr 7:871–878
10. Cohen MG, Rossi JS, Garbarino J, Bowling R, Motsinger-Reif AA, Sculer C, Dupont AG, Gabriel D (2011) Insights into the inhibition of platelet activation by omega-3 polyunsaturated fatty acids: Beyond aspirin and clopidogrel. Thromb Res 128(4):335–40
11. Covington MB (2004) Omega-3 fatty acids. Am Fam Physician 70:133–40
12. Cunnane SC, McAdoo KR, Horrobin DF (1986) n-3 essential fatty acids decrease weight gain in genetically obese mice. Br J Nutr 56:87–95
13. Darvall KAL, Sam RC, Silverman SH, Bradbury AW, Adam DJ (2007) Obesity and thrombosis. Eur J Vasc Endovasc Surg 33:223–33
14. Davi G, Guagnano MT, Ciabattoni G et al (2002) Platelet activation in obese women: Role of inflammation and oxidant stress. JAMA 288(16):2008–2014
15. De Pergola G, Pannacciulli N, Coviello M et al (2008) sP-selectin plasma levels in obesity: Association with insulin resistance and related metabolic and prothrombotic factors. Nutr Metab Cardiovasc Dis 18(3):227–232
16. Dieterich KD, Lehnert H, De Souza EB (1997) Corticotropin releasing factor receptors: an overview. Exp Clin Endocrinol Diabetes 105:65–82
17. Diniz YS, Faine LA, Almeida JA, Silva MDP, Ribas BO, Novelli ELB (2002) Toxicity of dietary restriction of fat enriched diets on cardiac tissue. Food Chem Toxicol 40:1892–1899
18. Fekete EM, Zorrilla EP (2007) Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: Ancient CRF paralogs. Front Neuroendocrinol 28:1–27
19. Flachs P, Horakova O, Brauner P, Rossmeisl M, Pecina P, Franssen-van Hal N, Ruzickova J, Sponarova J, Drahota Z et al (2005) Polyunsaturated fatty acids of marine origin upregulate mitochondrial biogenesis and induce beta-oxidation in white fat. Diabetologia 48:2365–75
20. Food and Drug Administration (FDA) (1997) Substances affirmed as generally recognized as safe: menhaden oil. Fed Reg 62:30751–7
21. Golub N, Geba D, Mousa SA, Williams G, Block RC (2011) Greasing the wheels of managing overweight and obesity with omega-3 fatty acids. Med Hypotheses 77:1114–1120
22. Hainault I, Carolotti M, Hajduch E, Guichard C, Lavau M (1993) Fish oil in a high lard diet prevents obesity, hyperlipemia, and adipocyte insulin resistance in rats. Ann NY Acad Sci 683:98–101
23. Harris WS, Miller M, Tighe AP, Davidson MH, Schaefer EJ (2008) Omega-3 fatty acids and coronary heart disease risk: Clinical and mechanistic perspectives. Atherosclerosis 197:12–24
24. Hendra T, Betteridge DJ (1989) Platelet function, platelet prostanoids, and vascular prostacyclin in DM. Prostaglandins Leukot Essent Fatty Acids 35:197–212
25. Hill JO (2006) Understanding and addressing the epidemic of obesity: an energy balance perspective. Endocr Rev 27:750e61
26. Ivy AC, Nelson D, Bucher G (1940) Clotting time analysis. J Lab Clin Med 26:182
27. Kalupahana NS, Claycombe KJ, Moustaid-Moussa N (2011) (n-3) Fatty acids alleviate adipose tissue inflammation and insulin resistance: Mechanistic insights. Adv Nutr 2:304–316
28. Kalupahana NS, Claycombe KJ, Newman SJ, Stewart T, Siriwardhana N, Matthan N, Lichtenstein AH, Moustaid-Moussa N (2010) Eicosapentaenoic acid prevents and reverses insulin resistance in high-fat diet induced obese mice via modulation of adipose tissue inflammation. J Nutr 140:1915–22
29. Kastin AJ, Pan W, Akerstrom V, Hackler L, Wang C, Kotz CM (2002) Novel peptide-peptide cooperation may transform feeding behavior. Peptides 23:2189–2196
30. Kelly T, Yang W, Chen CS et al (2008) Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond) 32:1431–1437
31. Kinney JW, Scrmggs B, Avery DD (2000) Peripheral administration of urocortin suppresses operant responding for food reward. Peptides 22:583–587
32. Kris-Etherton PM, Harris WS, Appel LJ (2003) Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Arterioscler Thromb Vasc Biol 23:151–152
33. Kuda O, Jelenik T, Jilkova Z, Flachs P, Rossmeisl M, Hensler M, Kazdova L, Ogston N, Baranowski M et al (2009) n-3 fatty acids and rosiglitazone improve insulin sensitivity through additive stimulatory effects on muscle glycogen synthesis in mice fed a high-fat diet. Diabetologia 52:941–51
34. Lemini C, Rubio-Póo C, Silva G, Garcia-Mondragon J, Zavala E, Mendoza-Patiño N, Castro D, Cruz-Almanza R, Mandoki JJ (1993) Anticoagulant and estrogenic effects of two new 17β-aminoestrogens, butolame [17β-(4-hydroxy-1-butylamino)-1, 3,5(10)-estratrien-3-ol] and pentolame [17β-(5-hydroxy-1-pentylamino)-1, 3,5(10)-estratrien-3-ol]. Steroids 58:457–461
35. Madsen L, Rustan AC, Vaagenes H, Berge K, Dyroy E, Berge RK (1999) Eicosapentaenoic and docosahexaenoic acid affect mitochondrial and peroxisomal fatty acid oxidation in relation to substrate preference. Lipids 34:951–63
36. Matyšková R, Maletínská L, Maixnerová J, Pirník Z, Kiss A, Zelezná B (2008) Comparison of the obesity phenotypes related to monosodium glutamate effect on arcuate nucleus and/or the high fat diet feeding in C57Bl/6 and NMRI mice. Physiol Res 57:727–734
37. Meganathan M, Gopal MK, Sasikala P, Mohan J, Gowdhaman N, Balamurugan K, Nirmala P, Santhakumari S, Samuel V (2011) Evaluation of hepatoprotective effect of omega 3-fatty acid against paracetamol induced liver injury in Albino Rats. Glob J Pharmacol 5(1):50–53
38. Mertens I, Van Gaal LF (2002) Obesity, haemostasis and the fibrinolytic system. Obes Rev 3:85–101
39. Meydan S, Altas M, Nacar A, Ozturk OH, Tas U, Zararsiz I, Sarsilmaz M (2012) The protective effects of omega-3 fatty acid against toluene-induced neurotoxicity in prefrontal cortex of rats. Hum Exp Toxicol 31(11):1179–85
40. Micallef M, Munro I, Phang M, Garg M (2009) Plasma n − 3 polyunsaturated fatty acids are negatively associated with obesity. Br J Nutr 102:1370–1374
41. Mustard JF, Hegard TB, RowSell HC (1964) Effects of adenosine nucleotides on platelet aggregation and clotting time. J Lab Clin Med 64:548
42. Nascimento AF, Sugizaki MM, Leopoldo AS, Lima-Leopoldo AP, Nogueira CR, Novelli EL, Padovani CR, Cicogna AC (2008) Misclassification probability as obese or lean in hypercaloric and normocaloric diet. Biol Res 41(3):253–9
43. Nozu T, Martinez V, Rivier J, Tache Y (1999) Peripheral urocortin delays gastric emptying: Role of CRF receptor 2. Am J Physiol Gastrointest Liver Physiol 276:G867–G874
44. Oosthuizen W, Vorster HH, Jerling JC, Barnard HC, Smuts CM, Silvis N, Kruger A, Venter CS (1994) Both fish and olive oil lowered plasma fibrinogen in women with high baseline fibrinogen levels. Thromb Haemost 72:557–562
45. Parrish CC, Pathy DA, Angel A (1990) Dietary fish oils limit adipose tissue hypertrophy in rats. Metabolism 39:217–219
46. Perrin MH, Sutton SW, Cervini LA, Rivier JE, Vale WW (1999) Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of CRF receptors. J Pharmacol Exp Ther 288:729–734
47. + currents. J Muscle Res Cell Motil 21:639–645
48. Phang M, Lincz LF, Garg ML (2013) Eicosapentaenoic and docosahexaenoic acid supplementations reduce platelet aggregation and hemostatic markers differentially in men and women. J Nutr 143:457–463
49. Phillips RJ, Powley TL (1996) Gastric volume rather than nutrient content inhibits food intake. Am J Physiol 271:R766–R769
50. Puglisi MJ, Hasty AH, Saraswathi V (2011) The role of adipose tissue in mediating the beneficial effects of dietary fish oil. J Nutr Biochem 22:101–8
51. Reagan-Shaw S, Nihal M, Ahmad N (2007) Dose translation from animal to human studies revisited. FASEB J 22:659–661
52. Robinson JG, Stone NJ (2006) Antiatherosclerotic and antithrombotic effects of omega-3 fatty acids. Am J Cardiol 98:39––49i
53. Rustan AC, Nossen JO, Christiansen EN, Drevon CA (1988) Eicosapentaenoic acid reduces hepatic synthesis and secretion of triacylglycerol by decreasing the activity of acyl-coenzyme A:1,2-diacylglycerol acyl-transferase. J Lipid Res 29:1417–26
54. Saruta M, Takahashi K, Suzuki T, Torii A, Kawakami M, Sasano H (2004) Urocortin 1 in colonic mucosa in patients with ulcerative colitis. J Clin Endocrinol Metab 89:5352–5361
55. Schenk S, Saberi M, Olefsky JM (2008) Insulin sensitivity: Modulation by nutrients and inflammation. J Clin Invest 118:2992–3002
56. Schwab JM, Chiang N, Arita M, Serhan CN (2007) Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 447:869–74
57. Srinivasan M, Katewa SD, Palaniyappan A, Pandya JD, Patel MS (2006) Maternal high-fat diet consumption results in fetal malprogramming predisposing to the onset of metabolic syndrome-like phenotype in adulthood. Am J Physiol Endocrinol Metab 29:E792–E799
58. Tanaka C, Asakawa A, Ushikai M et al (2009) Comparison of the anorexigenic activity of CRF family peptides. Biochem Biophys Res Commun 390:887–891
59. Targher G, Zoppini G, Moghetti P, Day CP (2010) Disorders of coagulation and hemostasis in abdominal obesity: Emerging role of fatty liver. Semin Thromb Hemost 36:41–48
60. Todoric J, Loffler M, Huber J, Bilban M, Reimers M, Kadl A, Zeyda M, Waldhausl W, Stulnig TM (2006) Adipose tissue inflammation induced by high-fat diet in obese diabetic mice is prevented by n-3 polyunsatu-rated fatty acids. Diabetologia 49:2109–19
61. Vanschoonbeek K, de Maat MP, Heemskerk JWM (2003) Fish oil consumption and reduction of arterial disease. J Nutr 133:657–660
62. Vanschoonbeek K, Feijge MA, Paquay M, Rosing J, Saris W, Kluft C, Giesen PL, de Maat MP, Heemskerk JW (2004) Variable hypocoagulant effect of fish oil intake in humans: Modulation of fibrinogen level and thrombin generation. Arterioscler Thromb Vasc Biol 24(9):1734–40
63. Vasconcelos EM, Degasperi GR, de Oliveira HC, Vercesi AE, de Faria EC, Castilho LN (2009) Reactive oxygen species generation in peripheral blood monocytes and oxidized LDL are increased in hyperlipidemic patients. Clin Biochem 42:1222–7
64. Vaughan JM, Donaldson C, Bittencourt J, Perrin MH, Lewis K, Sutton S, Chan R, Turnbull A, Lovejoy D, Rivier C et al (1995) Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 378:287–292
65. Von Diemen V, Trindade EN, Trindade MR (2006) Experimental model to induce obesity in rats. Acta Cir Bras 21(6):425–429
66. Wang L, Marti’nez V, Rivier JE, Tache’ Y (2001) Peripheral urocortin inhibits gastric emptying and food intake in mice: Differential role of CRF receptor 2. Am J Physiol Regul Integr Comp Physiol 281:R1401
67. Xu Y, Zhang R, Chen J, Zhang Q, Wang J, Hu J, Guan X, Jin L, Fu H, Gui B, Guo Y, Li S (2009) Urocortin promotes the development of vasculitis in a rat model of thromboangiitis obliterans via corticotrophin-releasing factor type 1 receptors. Br J Pharmacol 157:1368–1379
68. Youssef MHM, Saleh NKM, Mohamed AA, El Khatib YA (2010) Enhanced platelet aggregation, hyperinsulinemia and low testosterone level in monosodium glutamate obese rats. Aust J Basic Appl Sci 4(10):4532–4539
69. Zorad S, Jezova D, Szabova L, Macho L, Tybitanclova K (2003) Low Number of insulin receptors but high receptor protein content in adipose tissue of rats with monosodium glutamate-induced obesity. Gen Physiol Biophys 22:557–560